{"id":"W4395464611","doi":"10.51731/cjht.2024.875","title":"Sacituzumab Govitecan (Trodelvy)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Immunohistochemistry; Medicine; Human Epidermal Growth Factor Receptor 2; Oncology; Metastatic breast cancer; Internal medicine; Family medicine; Cancer; Breast cancer; Political science","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000586769,0.0002037475,0.0002648444,0.001041945,0.0001728629,0.0006887445,0.0002796764,0.0003231736,0.004849331],"category_scores_gemma":[0.0007088154,0.00006565288,0.0003406394,0.000786415,0.0002216067,0.0002462925,0.0001677557,0.0004313819,0.001034634],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002040829,"about_ca_system_score_gemma":0.002143241,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01667534,"about_ca_topic_score_gemma":0.08659583,"domain_scores_codex":[0.9996183,0.00007310419,0.00002496661,0.00003225248,0.000215198,0.00003614054],"domain_scores_gemma":[0.9997215,0.00005551618,0.00006702204,0.000007897295,0.000119057,0.00002902537],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004589912,0.0000574652,0.001116251,0.00298585,0.0001533034,0.0001695948,0.00003822853,0.0003365646,0.005930348,0.002569692,0.03938471,0.946799],"study_design_scores_gemma":[0.0003489646,0.0008454892,0.006953319,0.002280819,0.0002988287,0.001511406,0.00006640255,0.0002676855,0.005416973,0.0004964178,0.9814954,0.00001829694],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02833088,0.8634068,0.001202296,0.004078837,0.0006952055,0.0003009349,0.001664005,0.0001946396,0.1001265],"genre_scores_gemma":[0.2779047,0.6577558,0.003380914,0.004107879,0.0004950856,0.000189664,0.003017782,0.00004355143,0.05310462],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01667534,"threshold_uncertainty_score":0.03315657,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06053561742653599,"score_gpt":0.3863126043444558,"score_spread":0.3257769869179198,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}